Want to see IN:ANURAS full AI Analyst Report?
ANURAS Stock Chart & Stats
₹1249.20
-₹26.30(-2.10%)
At close: 4:00 PM EDT
₹1249.20
-₹26.30(-2.10%)
Day’s Range― - ―
52-Week Range₹1,047.40 - ₹1,415.40
Previous CloseN/A
Volume145.79K
Average Volume (3M)7.28K
Market Cap
₹137.37B
Enterprise Value₹131.26K
Total Cash (Recent Filing)₹4.11B
Total Debt (Recent Filing)₹18.67B
Price to Earnings (P/E)80.1
Beta0.59
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.12%
Share Statistics
EPS (TTM)15.09
Shares Outstanding113,848,310
10 Day Avg. Volume10,749
30 Day Avg. Volume7,276
Financial Highlights & Ratios
PEG Ratio1.05
Price to Book (P/B)4.16
Price to Sales (P/S)5.87
P/FCF Ratio-38.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)17.45
Revenue Forecast (FY)₹23.71B
Bulls Say, Bears Say
Bulls Say
Contract/custom Synthesis ModelANURAS's contract/custom synthesis model focuses on customer-specific complex molecules and long-term supply relationships. That technical differentiation and customer stickiness support repeat revenue, multi-year product life cycles, and durable demand across agro, pharma and export markets.
Revenue Rebound And Solid MarginsA clear FY2026 revenue rebound alongside mid-30s gross margin and ~22% EBITDA margin indicates operational resilience and recovering end-market demand. Sustained positive margins of this scale support reinvestment and coverage of fixed costs, helping sustain long-term manufacturing economics.
Scale And Equity BufferA large asset base (~80.1B) and sizable equity (~33.3B) provide financial and operational capacity for capacity expansion, multi-step process investments and long-term customer contracts. This balance-sheet scale reduces insolvency risk and underpins credible multi-year execution.
Bears Say
Persistently Negative Free Cash FlowMaterial negative FCF (~-3.6B in FY2026) despite operating cash flow recovery (~2.0B) points to heavy capex or working-capital drag. Persistent weak cash conversion limits the company's ability to self-fund growth, raising reliance on external financing and execution risk over the medium term.
Rising LeverageDebt-to-equity rising materially over recent years increases interest cost exposure and reduces financial flexibility. Higher leverage constrains ability to absorb margin volatility or pursue opportunistic investments, making the company more sensitive to cyclical downturns in end markets.
Margins Compressed Versus Prior YearsAlthough profitability is positive, margins remain below earlier peaks, suggesting structural margin pressure from mix, pricing or cost shifts. Lower margins reduce cash generation and the operational cushion available for reinvestment, increasing sensitivity to cost or demand shocks over time.
Anupam Rasayan India Ltd. News
ANURAS FAQ
What was Anupam Rasayan India Ltd.’s price range in the past 12 months?
Anupam Rasayan India Ltd. lowest stock price was ₹1047.40 and its highest was ₹1415.40 in the past 12 months.
What is Anupam Rasayan India Ltd.’s market cap?
Anupam Rasayan India Ltd.’s market cap is ₹137.37B.
When is Anupam Rasayan India Ltd.’s upcoming earnings report date?
Anupam Rasayan India Ltd.’s upcoming earnings report date is Nov 11, 2026 which is in 88 days.
How were Anupam Rasayan India Ltd.’s earnings last quarter?
Anupam Rasayan India Ltd. released its earnings results on Aug 14, 2026. The company reported ₹3.2 earnings per share for the quarter, the consensus estimate of ₹3.2 by ₹0.
Is Anupam Rasayan India Ltd. overvalued?
According to Wall Street analysts Anupam Rasayan India Ltd.’s price is currently Overvalued.
Does Anupam Rasayan India Ltd. pay dividends?
Anupam Rasayan India Ltd. pays a Annually dividend of ₹0.75 which represents an annual dividend yield of 0.12%. See more information on Anupam Rasayan India Ltd. dividends here
What is Anupam Rasayan India Ltd.’s EPS estimate?
Anupam Rasayan India Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anupam Rasayan India Ltd. have?
Anupam Rasayan India Ltd. has 113,848,310 shares outstanding.
What happened to Anupam Rasayan India Ltd.’s price movement after its last earnings report?
Anupam Rasayan India Ltd. reported an EPS of ₹3.2 in its last earnings report, expectations of ₹3.2. Following the earnings report the stock price went up 0.195%.
Which hedge fund is a major shareholder of Anupam Rasayan India Ltd.?
Currently, no hedge funds are holding shares in IN:ANURAS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Anupam Rasayan India Ltd.
Anupam Rasayan India Ltd., established in Surat, India, in 1984, specializes in the custom synthesis and production of specialty chemicals. The company manufactures a diverse range of life science-oriented chemicals, including intermediates and active ingredients crucial for the agrochemical sector, alongside compounds for antibacterial and ultraviolet protection applications in the personal care industry. Additionally, it provides essential intermediates and key starting materials vital for active pharmaceutical ingredients. Beyond these life science applications, Anupam Rasayan also supplies other specialized chemicals to various end-user segments, such as specialty pigments, dyes, and polymer additives. The company distributes its products both domestically and through exports.
Technical Analysis
AARTI Industries Ltd
―
Aether Industries Ltd.
―
Alkyl Amines Chemicals Limited
―
Atul Limited
―
Jubilant Ingrevia Ltd.
―